| Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study C DeBoever, Y Tanigawa, ME Lindholm, G McInnes, A Lavertu, ... Nature communications 9 (1), 1612, 2018 | 109 | 2018 |
| Frameshift indels introduced by genome editing can lead to in-frame exon skipping S Lalonde, OA Stone, S Lessard, A Lavertu, J Desjardins, M Beaudoin, ... PloS one 12 (6), e0178700, 2017 | 108 | 2017 |
| Pharmacogenetics at scale: an analysis of the UK Biobank G McInnes, A Lavertu, K Sangkuhl, TE Klein, M Whirl‐Carrillo, RB Altman Clinical Pharmacology & Therapeutics 109 (6), 1528-1537, 2021 | 101 | 2021 |
| Global Biobank Engine: enabling genotype-phenotype browsing for biobank summary statistics G McInnes, Y Tanigawa, C DeBoever, A Lavertu, JE Olivieri, M Aguirre, ... Bioinformatics 35 (14), 2495-2497, 2019 | 98 | 2019 |
| Pharmacogenomics clinical annotation tool (Pharm CAT) K Sangkuhl, M Whirl‐Carrillo, RM Whaley, M Woon, A Lavertu, RB Altman, ... Clinical Pharmacology & Therapeutics 107 (1), 203-210, 2020 | 73 | 2020 |
| A new era in pharmacovigilance: Toward real‐world data and digital monitoring A Lavertu, B Vora, KM Giacomini, R Altman, S Rensi Clinical Pharmacology & Therapeutics 109 (5), 1197-1202, 2021 | 62 | 2021 |
| Assessing digital phenotyping to enhance genetic studies of human diseases C DeBoever, Y Tanigawa, M Aguirre, G McInnes, A Lavertu, MA Rivas The American Journal of Human Genetics 106 (5), 611-622, 2020 | 53 | 2020 |
| Pharmacogenomics and big genomic data: from lab to clinic and back again A Lavertu, G McInnes, R Daneshjou, M Whirl-Carrillo, TE Klein, ... Human molecular genetics 27 (R1), R72-R78, 2018 | 30 | 2018 |
| RedMed: Extending drug lexicons for social media applications A Lavertu, RB Altman Journal of Biomedical Informatics 99, 103307, 2019 | 26 | 2019 |
| Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteins DW Morgens, C Chan, AJ Kane, NR Weir, A Li, MM Dubreuil, CK Tsui, ... Elife 8, e48434, 2019 | 17 | 2019 |
| Quantifying the severity of adverse drug reactions using social media: network analysis A Lavertu, T Hamamsy, RB Altman Journal of Medical Internet Research 23 (10), e27714, 2021 | 13* | 2021 |
| # Science: The potential and the challenges of utilizing social media and other electronic communication platforms in health care V Gijsen, M Maddux, A Lavertu, G Gonzalez‐Hernandez, N Ram, ... Clinical and Translational Science, 2019 | 12 | 2019 |
| Monitoring the opioid epidemic via social media discussions A Lavertu, T Hamamsy, RB Altman MedRxiv, 2021.04. 01.21254815, 2021 | 7 | 2021 |
| LPA and APOE are associated with statin selection in the UK Biobank A Lavertu, G McInnes, Y Tanigawa, RB Altman, MA Rivas bioRxiv, 2020.08. 28.272765, 2020 | 6 | 2020 |
| Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study. Nat Commun. 2018; 9: 1612 C DeBoever, Y Tanigawa, ME Lindholm, G McInnes, A Lavertu, ... | 5 | |
| Genome-Wide Analysis of Cell Cycle-Regulating Genes in the Symbiotic Dinoflagellate Breviolum minutum ML Cato, HD Jester, A Lavertu, A Lyman, LM Tallent, GC Mitchell G3: Genes, Genomes, Genetics 9 (11), 3843-3853, 2019 | 4 | 2019 |
| Repurposing biomedical informaticians for COVID-19 DN Sosa, B Chen, A Kaushal, A Lavertu, J Lever, S Rensi, R Altman Journal of Biomedical Informatics 115, 103673, 2021 | 2 | 2021 |
| A Year of Papers Using Biomedical Texts C Grouin, N Grabar Yearbook of Medical Informatics 29 (01), 221-225, 2020 | 2 | 2020 |
| Covid Fast Fax: A system for real-time triage of Covid-19 case report faxes A Lavertu, A Stribling, M White, G McInnes, RB Altman, R Pramanik, ... medRxiv, 2020.12. 15.20248256, 2020 | 1 | 2020 |
| Methods for Leveraging Social Media Data to Quantify and Improve Pharmacovigilance Efforts AAJ Lavertu Stanford University, 2021 | | 2021 |
Russ B AltmanProfessor Stanford UniversityПодтвержден адрес электронной почты в домене stanford.edu
